≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Use of selegiline

PheWeb

PDMED_SELEGILINE

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N04BD01

1493

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

1105

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

1105

diagram downward connector

Include endpoints None

1105

diagram downward connector
PDMED_SELEGILINE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 1105 455 650
Unadjusted prevalence (%) 0.31 0.23 0.41
Mean age at first event (years) 63.66 62.07 64.77

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.52 [2.48, 4.98] 1.3e-12 337
15 years 0.02 2.61 [2.06, 3.31] 1.4e-15 206
5 years 0.00 2.81 [2.15, 3.67] 5.1e-14 86
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: PDMED_SELEGILINE – Use of selegiline
GWS hits:

Survival analyses between endpoints

↥

Plot

before Use of selegiline
after Use of selegiline

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of selegiline

↥